Rite Aid Corp (RAD)
$5.60 0.18 (3.11%)
12:15 EDT RAD Stock Quote Delayed 15 Minutes
Previous Close $3.81
Market Cap 5.97B
PE Ratio -16.47
Volume (Avg. Vol.) 684,328
Day's Range 5.46 - 5.85
52-Week Range 0.43 - 11.37
Dividend & Yield N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
- From InvestorPlace
- From the Web
A unique Amazon partnership provides a glimmer of hope for RAD stock, but don't bet on that glimmer of hope until it gets brighter.
Heyward Donigan isn't the reason RAD stock has tanked of late. But, if she doesn't appreciate where Rite Aid is wasting money, she may be the reason Rite Aid stock continues to lose ground.
A package pick-up service sounds promising for Rite Aid, but just like the RAD stock price chart, it’s an uphill battle.
The Amazon catalyst gives RAD stock unique breakout potential from today's depressed levels, but that potential is accompanied by ample risk.
Fundamentally, speculators in Rite Aid stock are ignoring the demographic tailwind that the retail pharmacy’s deal with Amazon provides.
Over the years, CVS stock has incurred some painful losses in the markets. However, bold moves by management make this a compelling contrarian buy.
Rite Aid, iQiyi, KB Home, Pier 1 and ConAgra are all on the move Thursday. Here are our top stock trades as a result.
CVS stock has been bleeding for four years. Now, the light at the end of the tunnel is here for CVS Health.
The stock charts of FITB, MRO and INFO stock are on the verge of major moves. Here's what to look for today.
Walgreens stock tanked after the company reported weak second-quarter results and issued a light outlook, but there's opportunity here.
Canopy Growth, CVS Health, Intercept Pharmaceuticals, Rite Aid and UnitedHealth are our top stock trades to watch for Friday.
Rite Aid (RAD) announced the pharmacy/retailer will sell CBD products in Washington and Oregon this month, including lip balms and lotions.
The Rite Aid earnings for the company's fiscal fourth quarter of the year has RAD stock falling hard on Thursday with a revenue miss.
Rite Aid has a new management team. Unfortunately, its predecessors left them with one incredible mess to clean up.
With the longest bull market hanging in the balance this earnings season, these stocks to watch could be the difference-maker.
It's not a reason to buy Walgreens stock in and of itself, but it certainly doesn't hurt the bullish case.
There were some big movers in both directions today -- including ACB stock, so let’s get a look at our top stock trades moving forward.
Rite Aid has failed to tie-up with Walgreens and Albertsons. With a reverse split of RAD stock, a suitor may emerge.
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!